Legislators in the state of New York recently filed an amended measure to legalize psychedelics. The measure, introduced by Assemblymember Linda Rosenthal, was revised to include provisions allowing the growing, possession, sanctioned use, exchange, sharing and gifting of entheogenic plants and fungi in therapeutic and ceremonial settings for individuals aged 21 and above.
The revision was drawn up with input from various advocacy groups, including the Decriminalize Nature chapter of New York, Students for Sensible Drug Policy NY, Hudson Valley Psychedelic Society and Decrim First NY.
The amended measure was filed early last week, setting the stage for legislative action in next year’s session. This gives legislators more time to contemplate the new provisions.
The measure was originally introduced last year and, had it been approved, would have removed psilocin and psilocybin from the state’s list of controlled substances, leading to the legalization of these compounds. Other entheogenic plants and fungi included are mescaline and ibogaine. Psilocybin is the active compound found in hallucinogenic mushrooms that induces a high.
The revised bill now contains various protections for individuals who use the natural substances in compliance with state law and offers a stronger regulatory framework for an extensive range of psychedelics. It will also permit the guidance, supervision, spiritual, religious, peers engaging in risk mitigation and associated support services for psychedelics, without or with remuneration. Religious organizations and noncommercial entities will also be authorized to cultivate, possess, exchange and administer the included entheogens.
In addition, the bill stipulates that local and state law enforcement will not cooperate with offering assistance to the federal government or any agency in enforcing the Controlled Substances Act, in regards to cases associated with psychedelic activities made legal.
A justification memo attached to the revised measure states that the failed war on drugs has resulted in grave consequences for individuals across the country. The memo also noted that the criminalization of some substances has left many incarcerated while preventing others from accessing entheogens, which could offer relief in managing mental health conditions, chronic pain, substance use disorders and other health conditions.
Further, the amended resolution includes provisions offering legal protections for individuals who use psychedelics legally. This includes sections that prevent adverse employment actions and the revocation or denial of business licenses. Localities in the state will also not be permitted to enact laws that criminalize psychedelic substances.
This wave of policy reform with regard to psychedelics is coming at a time when many companies such as Silo Pharma Inc. (NASDAQ: SILO) are taking major strides toward developing medicines that could potentially revolutionize the way different illnesses, including mental health conditions, have been treated in the past.
NOTE TO INVESTORS: The latest news and updates relating to Silo Pharma Inc. (NASDAQ: SILO) are available in the company’s newsroom at https://ibn.fm/SILO
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.